Focused ultrasound and interleukin-4 receptor-targeted liposomal doxorubicin for enhanced targeted drug delivery and antitumor effect in glioblastoma multiforme

Journal of Controlled Release

Volumn 160, Issue 3, 2012, Pages 652-658

  Yang, Feng Yi ^a   Wong, Tai Tong ^b   Teng, Ming Che ^a   Liu, Ren Shyan ^a,b   Lu, Maggie ^c   Liang, Hsiang Fa ^c   Wei, Ming Cheng ^c  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE   (Taiwan)

Author keywords

AP 1; Blood brain barrier; Brain tumor; Focused ultrasound; Targeted drug delivery

Indexed keywords

AP-1; BLOOD-BRAIN BARRIER; BRAIN TUMORS; FOCUSED ULTRASOUND; TARGETED DRUG DELIVERY;

BLOOD; BRAIN; CHEMOTHERAPY; DRUG DELIVERY; LIPOSOMES; MAMMALS; SONICATION; ULTRASONICS;

TUMORS;

DOXORUBICIN; INTERLEUKIN 4;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BLOOD BRAIN BARRIER; BRAIN TUMOR; CANCER INHIBITION; CONTROLLED STUDY; DRUG EFFICACY; FLUOROMETER; GLIOBLASTOMA; HIGH INTENSITY FOCUSED ULTRASOUND; HUMAN; HUMAN CELL; LIPOSOMAL DELIVERY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SURVIVAL TIME; TUMOR CELL; TUMOR XENOGRAFT;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; BRAIN NEOPLASMS; CELL LINE, TUMOR; COMBINED MODALITY THERAPY; DOXORUBICIN; GLIOBLASTOMA; HIGH-INTENSITY FOCUSED ULTRASOUND ABLATION; HUMANS; LIPOSOMES; MICE; PEPTIDES; RECEPTORS, INTERLEUKIN-4; TUMOR BURDEN; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84861985598     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2012.02.023     Document Type: Article

References (34)

1. J.D. Floyd, D.T. Nguyen, R.L. Lobins, Q. Bashir, D.C. Doll, M.C. Perry, Cardiotoxicity of cancer therapy, J. Clin. Oncol. 23 (30) (2005) 7685-7696. (Pubitemid 46291833)
2. T.M. Allen, P.R. Cullis, Drug delivery systems: entering the mainstream, Science 303 (5665) (2004) 1818-1822. (Pubitemid 38374867)
3. T.M. Allen, Liposomes. Opportunities in drug delivery, Drugs 54 (Suppl. 4) (1997) 8-14. (Pubitemid 27487790)
4. C.R. Dass, T.L. Walker, M.A. Burton, E.E. Decruz, Enhanced anticancer therapy mediated by specialized liposomes, J. Pharm. Pharmacol. 49 (10) (1997) 972-975. (Pubitemid 27478388)
5. R.K. Puri, P. Leland, R.J. Kreitman, I. Pastan, Human neurological cancer cells express interleukin-4 (IL-4) receptors which are targets for the toxic effects of IL4-Pseudomonas exotoxin chimeric protein, Int. J. Cancer 58 (4) (1994) 574-581. (Pubitemid 24268102)
6. B.H. Joshi, P. Leland, A. Asher, R.A. Prayson, F. Varricchio, R.K. Puri, In situ expression of interleukin-4 (IL-4) receptors in human brain tumors and cytotoxicity of a recombinant IL-4 cytotoxin in primary glioblastoma cell cultures, Cancer Res. 61 (22) (2001) 8058-8061. (Pubitemid 33091589)
7. S.R. Husain, N. Behari, R.J. Kreitman, I. Pastan, R.K. Puri, Complete regression of established human glioblastoma tumor xenograft by interleukin-4 toxin therapy, Cancer Res. 58 (16) (1998) 3649-3653. (Pubitemid 28376564)
8. M. Kioi, S. Takahashi, M. Kawakami, K. Kawakami, R.J. Kreitman, R.K. Puri, Expression and targeting of interleukin-4 receptor for primary and advanced ovarian cancer therapy, Cancer Res. 65 (18) (2005) 8388-8396. (Pubitemid 41330605)
9. L. Garland, B. Gitlitz, S. Ebbinghaus, H. Pan, H. de Haan, R.K. Puri, D. Von Hoff, R. Figlin, Phase I trial of intravenous IL-4 pseudomonas exotoxin protein (NBI-3001) in patients with advanced solid tumors that express the IL-4 receptor, J. Immunother. 28 (4) (2005) 376-381. (Pubitemid 40962331)
10. F.Y. Yang,H.E.Wang,G.L. Lin, M.C. Teng,H.H. Lin, T.T.Wong, R.S. Liu,Micro-SPECT/CTbased pharmacokinetic analysis of 99mTc- diethylenetriaminepentaacetic acid in rats with blood-brain barrier disruption induced by focused ultrasound, J. Nucl. Med. 52 (3) (2011) 478-484.
11. F.Y. Yang, Y.S. Lin, K.H. Kang, T.K. Chao, Reversible blood-brain barrier disruption by repeated transcranial focused ultrasound allows enhanced extravasation, J. Control. Release 150 (1) (2011) 111-116.
12. K. Hynynen, N. McDannold, N. Vykhodtseva, F.A. Jolesz, Noninvasive MR imaging-guided focal opening of the blood-brain barrier in rabbits, Radiology 220 (3) (2001) 640-646. (Pubitemid 32799969)
13. F.Y. Yang, S.C. Horng, Y.S. Lin, Y.H. Kao, Association between contrast-enhanced MR images and blood-brain barrier disruption following transcranial focused ultrasound, J. Magn. Reson. Imaging 32 (3) (2010) 593-599.
14. F.Y. Yang, S.H. Liu, F.M. Ho, C.H. Chang, Effect of ultrasound contrast agent dose on the duration of focused-ultrasound-induced blood-brain barrier disruption, J. Acoust. Soc. Am. 126 (6) (2009) 3344-3349.
15. L.H. Treat, N. McDannold, N. Vykhodtseva, Y. Zhang, K. Tam, K. Hynynen, Targeted delivery of doxorubicin to the rat brain at therapeutic levels using MRI-guided focused ultrasound, Int. J. Cancer 121 (4) (2007) 901-907. (Pubitemid 47106223)
16. A.B. Madhankumar, B. Slagle-Webb, X. Wang, Q.X. Yang, D.A. Antonetti, P.A. Miller, J.M. Sheehan, J.R. Connor, Efficacy of interleukin-13 receptor-targeted liposomal doxorubicin in the intracranial brain tumor model, Mol. Cancer Ther. 8 (3) (2009) 648-654.
17. A.B. Madhankumar, B. Slagle-Webb, A. Mintz, J.M. Sheehan, J.R. Connor, Interleukin-13 receptor-targeted nanovesicles are a potential therapy for glioblastoma multiforme, Mol. Cancer Ther. 5 (12) (2006) 3162-3169. (Pubitemid 46092059)
18. H.Y. Hong, H.Y. Lee, W. Kwak, J. Yoo, M.H. Na, I.S. So, T.H. Kwon, H.S. Park, S. Huh, G.T. Oh, I.C. Kwon, I.S. Kim, B.H. Lee, Phage display selection of peptides that home to atherosclerotic plaques: IL-4 receptor as a candidate target in atherosclerosis, J. Cell. Mol. Med. 12 (5B) (2008) 2003-2014.
19. X.L. Wu, J.H. Kim, H. Koo, S.M. Bae, H. Shin, M.S. Kim, B.H. Lee, R.W. Park, I.S. Kim, K. Choi, I.C. Kwon, K. Kim, D.S. Lee, Tumor-targeting peptide conjugated pHresponsive micelles as a potential drug carrier for cancer therapy, Bioconjug. Chem. 21 (2) (2010) 208-213.
20. J.H. Kim, S.M. Bae, M.H. Na, H. Shin, Y.J. Yang, K.H. Min, K.Y. Choi, K. Kim, R.W. Park, I.C. Kwon, B.H. Lee, A.S. Hoffman, I.S. Kim, Facilitated intracellular delivery of peptide-guided nanoparticles in tumor tissues, J. Control. Release (2011).
21. F.Y. Yang, G.L. Lin, S.C. Horng, T.K. Chang, S.Y. Wu, T.T. Wong, H.E. Wang, Pulsed high-intensity focused ultrasound enhances the relative permeability of the blood-tumor barrier in a glioma-bearing rat model, IEEE Trans. Ultrason. Ferroelectr. Freq. Control 58 (5) (2011) 964-970.
22. N.R. Bachur, A.L. Moore, J.G. Bernstein, A. Liu, Tissue distribution and disposition of daunomycin (NCS-82151) in mice: fluorometric and isotopic methods, Cancer Chemother. Rep. 54 (2) (1970) 89-94.
23. A.O. Muda, S. Feriozzi, S. Rahimi, E. Ancarani, T. Faraggiana, Spatial arrangement of subepithelial deposits in lupus and nonlupus membranous nephropathy, Am. J. Kidney Dis. 34 (1) (1999) 85-91. (Pubitemid 29318800)
24. A.J. Primeau, A. Rendon, D. Hedley, L. Lilge, I.F. Tannock, The distribution of the anticancer drug doxorubicin in relation to blood vessels in solid tumors, Clin. Cancer Res. 11 (24 Pt 1) (2005) 8782-8788. (Pubitemid 43005929)
25. J. Lankelma, H. Dekker, F.R. Luque, S. Luykx, K. Hoekman, P. van der Valk, P.J. van Diest, H.M. Pinedo, Doxorubicin gradients in human breast cancer, Clin. Cancer Res. 5 (7) (1999) 1703-1707. (Pubitemid 29334449)
26. U.S. Sharma, A. Sharma, R.I. Chau, R.M. Straubinger, Liposome-mediated therapy of intracranial brain tumors in a rat model, Pharm. Res. 14 (8) (1997) 992-998. (Pubitemid 27371396)
27. Y. Manome, M. Nakamura, T. Ohno, H. Furuhata, Ultrasound facilitates transduction of naked plasmid DNA into colon carcinoma cells in vitro and in vivo, Hum. Gene Ther. 11 (11) (2000) 1521-1528. (Pubitemid 30670604)
28. V. Frenkel, A. Etherington, M. Greene, J. Quijano, J. Xie, F. Hunter, S. Dromi, K.C. Li, Delivery of liposomal doxorubicin (Doxil) in a breast cancer tumor model: investigation of potential enhancement by pulsed-high intensity focused ultrasound exposure, Acad. Radiol. 13 (4) (2006) 469-479.
29. A. Khaibullina, B.S. Jang, H. Sun, N. Le, S. Yu, V. Frenkel, J.A. Carrasquillo, I. Pastan, K.C. Li, C.H. Paik, Pulsed high-intensity focused ultrasound enhances uptake of radiolabeled monoclonal antibody to human epidermoid tumor in nude mice, J. Nucl. Med. 49 (2) (2008) 295-302. (Pubitemid 351225669)
30. K. Tachibana, T. Uchida, K. Ogawa, N. Yamashita, K. Tamura, Induction of cell-membrane porosity by ultrasound, Lancet 353 (9162) (1999) 1409. (Pubitemid 29192415)
31. A. van Wamel, K. Kooiman, M. Harteveld, M. Emmer, F.J. ten Cate, M. Versluis, N. de Jong, Vibrating microbubbles poking individual cells: drug transfer into cells via sonoporation, J. Control. Release 112 (2) (2006) 149-155.
32. G.T. Clement, P.J. White, R.L. King, N. McDannold, K. Hynynen, A magnetic resonance imaging-compatible, large-scale array for trans-skull ultrasound surgery and therapy, J. Ultrasound Med. 24 (8) (2005) 1117-1125. (Pubitemid 41061464)
33. M. Pernot, J.F. Aubry, M. Tanter, J.L. Thomas, M. Fink, High power transcranial beam steering for ultrasonic brain therapy, Phys. Med. Biol. 48 (16) (2003) 2577-2589. (Pubitemid 37069368)
34. K. Hynynen, F.A. Jolesz, Demonstration of potential noninvasive ultrasound brain therapy through an intact skull, Ultrasound Med. Biol. 24 (2) (1998) 275-283. (Pubitemid 28145716)